<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>With optimal clinical management of patients with <z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan syndrome</z:e>, life expectancy may be improved substantially from 32 years to a nearly <z:mpath ids='MPATH_458'>normal</z:mpath> life span </plain></SENT>
<SENT sid="1" pm="."><plain>Cornerstones of clinical management comprise genetic counseling, life-style management, and cardiovascular surveillance, which includes regular aortic imaging and <z:hpo ids='HP_0100584'>endocarditis</z:hpo> prophylaxis </plain></SENT>
<SENT sid="2" pm="."><plain>Prophylactic use of beta-blocking agents as well as timing of elective surgery and the choice of the optimal surgical technique are difficult issues that obviously need to be individualized </plain></SENT>
<SENT sid="3" pm="."><plain>Juvenile or postoperative patients as well as pregnant patients with <z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan syndrome</z:e> pose particular problems </plain></SENT>
<SENT sid="4" pm="."><plain>This review intends both to facilitate differential decision making based on referenced evidence and to provide guidelines for therapeutic strategies </plain></SENT>
<SENT sid="5" pm="."><plain>Finally, a review of the most recent advances to somatic gene therapy is given </plain></SENT>
</text></document>